99 results
Page 4 of 5
8-K
EX-99.1
k09x3zggaj nob0
8 May 19
Sientra Reports First Quarter 2019 Financial Results
4:01pm
8-K
EX-99.1
rr8m6om2qz
21 Mar 19
Sientra® Issues Statement in Response to FDA Post-Approval Study Warning Letter
4:40pm
8-K
EX-99.1
2f5dkwqxtr4gmuetoo
12 Mar 19
Sientra Reports Fourth Quarter and Full Year 2018 Financial Results
4:31pm
8-K
EX-99.1
3wxux 1l1ut
6 Nov 18
Sientra Reports Third Quarter 2018 Financial Results
4:05pm
8-K
EX-99.1
wpk9yvfh gbo3hj1
7 Aug 18
Sientra Reports Second Quarter 2018 Financial Results
12:00am
8-K
EX-99.1
u9dp97 7g8uvmod
9 May 18
Sientra Reports First Quarter 2018 Financial Results
4:10pm
424B5
j9wgk6a 5l6t3d98
4 May 18
Prospectus supplement for primary offering
6:13am
8-K
EX-1.1
c83lx4ls
4 May 18
Sientra Commences Public Offering of Common Stock
6:07am
424B5
hku1nkfr u64udz
30 Apr 18
Prospectus supplement for primary offering
7:05am